Clinical validation study of quantitative real-time PCR assay for detection and monitoring of BK virus nephropathy

Satoru Kudose, Jianli Dong

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BK virus (BKV) causes nephropathy (BKVN) in renal transplant patients, but monitoring of BKV loads provides an opportunity to prevent BKVN. However, because viral load measurement is not standardized, each laboratory must validate their methodology. We performed a retrospective analysis of 1371 plasma and 600 urine BKV loads measured by the laboratory developed real-time polymerase chain reaction (RT-PCR) of BKV DNA and 346 biopsies from 284 patients in our renal transplant program. We assessed the ability of plasma and urine viral loads to predict the presence of BKVN in biopsy using the receiver-operator characteristic curve. We determined that the cut-offs 3.7 and 7.2 log copies/ml have the best sensitivity (100% and 100%) and specificity (97.6% and 97.5%) for the detection of concurrent biopsy with BKVN by plasma and urine viral load, respectively. Also, we determined that the presence of at least two viral loads greater than 2.8 log copies/ ml for plasma and 6.4 log copies/ml for urine within 30 days of biopsy can detect BKVN with similar operating characteristics. Lastly, among pairs of urine and plasma viral loads from the same day, we found that 375 of 376 urine viral loads <4 log copies/ml were accompanied by plasma viral loads <2.6 log copies/ ml, a finding which can alleviate the need for plasma viral load for most patients. In summary, our RT-PCR of BKV DNA has good operating characteristics, and our findings above can help in development of a better strategy to monitor BKV.

Original languageEnglish (US)
Pages (from-to)455-460
Number of pages6
JournalAnnals of Clinical and Laboratory Science
Volume44
Issue number4
StatePublished - 2014

Fingerprint

BK Virus
Validation Studies
Viral Load
Viruses
Real-Time Polymerase Chain Reaction
Assays
Biopsy
Plasmas
Monitoring
Urine
Transplants
Polymerase chain reaction
Patient monitoring
Kidney
DNA
Clinical Studies
Physiologic Monitoring

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Immunology
  • Microbiology
  • Hematology
  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

@article{879894f77d054ac5b344c3b88f159dff,
title = "Clinical validation study of quantitative real-time PCR assay for detection and monitoring of BK virus nephropathy",
abstract = "BK virus (BKV) causes nephropathy (BKVN) in renal transplant patients, but monitoring of BKV loads provides an opportunity to prevent BKVN. However, because viral load measurement is not standardized, each laboratory must validate their methodology. We performed a retrospective analysis of 1371 plasma and 600 urine BKV loads measured by the laboratory developed real-time polymerase chain reaction (RT-PCR) of BKV DNA and 346 biopsies from 284 patients in our renal transplant program. We assessed the ability of plasma and urine viral loads to predict the presence of BKVN in biopsy using the receiver-operator characteristic curve. We determined that the cut-offs 3.7 and 7.2 log copies/ml have the best sensitivity (100{\%} and 100{\%}) and specificity (97.6{\%} and 97.5{\%}) for the detection of concurrent biopsy with BKVN by plasma and urine viral load, respectively. Also, we determined that the presence of at least two viral loads greater than 2.8 log copies/ ml for plasma and 6.4 log copies/ml for urine within 30 days of biopsy can detect BKVN with similar operating characteristics. Lastly, among pairs of urine and plasma viral loads from the same day, we found that 375 of 376 urine viral loads <4 log copies/ml were accompanied by plasma viral loads <2.6 log copies/ ml, a finding which can alleviate the need for plasma viral load for most patients. In summary, our RT-PCR of BKV DNA has good operating characteristics, and our findings above can help in development of a better strategy to monitor BKV.",
author = "Satoru Kudose and Jianli Dong",
year = "2014",
language = "English (US)",
volume = "44",
pages = "455--460",
journal = "Annals of Clinical and Laboratory Science",
issn = "0091-7370",
publisher = "Association of Clinical Scientists",
number = "4",

}

TY - JOUR

T1 - Clinical validation study of quantitative real-time PCR assay for detection and monitoring of BK virus nephropathy

AU - Kudose, Satoru

AU - Dong, Jianli

PY - 2014

Y1 - 2014

N2 - BK virus (BKV) causes nephropathy (BKVN) in renal transplant patients, but monitoring of BKV loads provides an opportunity to prevent BKVN. However, because viral load measurement is not standardized, each laboratory must validate their methodology. We performed a retrospective analysis of 1371 plasma and 600 urine BKV loads measured by the laboratory developed real-time polymerase chain reaction (RT-PCR) of BKV DNA and 346 biopsies from 284 patients in our renal transplant program. We assessed the ability of plasma and urine viral loads to predict the presence of BKVN in biopsy using the receiver-operator characteristic curve. We determined that the cut-offs 3.7 and 7.2 log copies/ml have the best sensitivity (100% and 100%) and specificity (97.6% and 97.5%) for the detection of concurrent biopsy with BKVN by plasma and urine viral load, respectively. Also, we determined that the presence of at least two viral loads greater than 2.8 log copies/ ml for plasma and 6.4 log copies/ml for urine within 30 days of biopsy can detect BKVN with similar operating characteristics. Lastly, among pairs of urine and plasma viral loads from the same day, we found that 375 of 376 urine viral loads <4 log copies/ml were accompanied by plasma viral loads <2.6 log copies/ ml, a finding which can alleviate the need for plasma viral load for most patients. In summary, our RT-PCR of BKV DNA has good operating characteristics, and our findings above can help in development of a better strategy to monitor BKV.

AB - BK virus (BKV) causes nephropathy (BKVN) in renal transplant patients, but monitoring of BKV loads provides an opportunity to prevent BKVN. However, because viral load measurement is not standardized, each laboratory must validate their methodology. We performed a retrospective analysis of 1371 plasma and 600 urine BKV loads measured by the laboratory developed real-time polymerase chain reaction (RT-PCR) of BKV DNA and 346 biopsies from 284 patients in our renal transplant program. We assessed the ability of plasma and urine viral loads to predict the presence of BKVN in biopsy using the receiver-operator characteristic curve. We determined that the cut-offs 3.7 and 7.2 log copies/ml have the best sensitivity (100% and 100%) and specificity (97.6% and 97.5%) for the detection of concurrent biopsy with BKVN by plasma and urine viral load, respectively. Also, we determined that the presence of at least two viral loads greater than 2.8 log copies/ ml for plasma and 6.4 log copies/ml for urine within 30 days of biopsy can detect BKVN with similar operating characteristics. Lastly, among pairs of urine and plasma viral loads from the same day, we found that 375 of 376 urine viral loads <4 log copies/ml were accompanied by plasma viral loads <2.6 log copies/ ml, a finding which can alleviate the need for plasma viral load for most patients. In summary, our RT-PCR of BKV DNA has good operating characteristics, and our findings above can help in development of a better strategy to monitor BKV.

UR - http://www.scopus.com/inward/record.url?scp=84910010583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910010583&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 455

EP - 460

JO - Annals of Clinical and Laboratory Science

JF - Annals of Clinical and Laboratory Science

SN - 0091-7370

IS - 4

ER -